Lv3
290 积分 2025-11-01 加入
The immunomodulatory effect of bone marrow stromal cells (BMSCs) on interleukin (IL)-23/IL-17-mediated ischemic stroke in mice
2个月前
已关闭
Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study
2个月前
已完结
French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025
5个月前
已完结
Brodalumab: A new way to inhibit IL ‐17 in psoriasis
5个月前
已完结
Long-term efficacy and safety of bimekizumab in real-world setting: a 52-week prospective study
5个月前
已完结
Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study
5个月前
已完结
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial
5个月前
已完结
Real-life use of apremilast for the treatment of psoriasis in patients with oncological comorbidities: a retrospective descriptive multicentre study in France
5个月前
已完结
Psoriasis: Comorbidities
5个月前
已完结
14030 Ten-year interim results from the ESPRIT registry: Real-world safety, effectiveness, and patient-reported outcomes of adalimumab for moderate to severe psoriasis
5个月前
已关闭
皖公网安备34019202002308
